China Aoxing wins GMP certification for new production facility

The certificate of compliance has a five-year term and was issued by the State Food and Drug Administration following a site inspection.

Good Manufacturing Practice (GMP) is a body of internationally accepted regulations set forth by drug agencies at many countries. GMP compliance ensures that pharmaceuticals, active ingredients and medical devices are produced and quality-controlled according to high standards.

Juan Yue Han, chairman and CEO of China Aoxing, said: “GMP compliance is the gold standard in quality assurance in the life science industry. It is a major achievement for us to receive this particular GMP certification in early 2009. This provides the foundation for the further development of China Aoxing.

“We are well positioned to manufacture pharmaceutical products in tablet dosage form in our modern production facility, as we are preparing for the launch of several important narcotic drugs in tablet dosage form in the foreseeable future, including tilidine, oxycodone, buprenorphine and others, which provide well-established medical benefit in treating cancer pain, moderate to severe pain, or related chronic health problems.”